Atherosclerosis and acute coronary events

American Journal of Cardiology

Volumn 82, Issue 10 B, 1998, Pages

  Dalager Pedersen, Søren ^a   Berg Ravn, Hanne ^a   Falk, Erling ^a  

^a Dept Cardiol Inst Exp Clin R ^*  (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; BLOOD CLOTTING; CONFERENCE PAPER; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY THROMBOSIS; FIBRINOLYSIS; HEART INFARCTION; HEMOSTASIS; HISTOPATHOLOGY; HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK ASSESSMENT; SUDDEN DEATH; UNSTABLE ANGINA PECTORIS;

EID: 0345148803     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(98)00721-8     Document Type: Conference Paper

References (32)

1. Falk E. Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis. Characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi. Br Heart J. 50:1983;127-134.
2. Davies M.J., Thomas A. Thrombosis and acute coronary artery lesions in sudden cardiac ischemic death. N Engl J Med. 310:1984;1137-1140.
3. Falk E. Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion. Circulation. 71:1985;699-708.
4. DeWood M.A., Spores J., Notske R., Mouser L.T., Burroughs R., Golden M.S., Lang H.T. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med. 303:1980;897-902.
5. Sherman C.T., Litvack F., Grundfest W., Lee M., Hickey A., Chaux A., Kass R., Blanche C., Matloff J., Morgenstern L. Coronary angioscopy in patients with unstable angina pectoris. N Engl J Med. 315:1986;913-919.
6. De Feyter P.J., Ozaki Y., Baptista J., Escaned J., Dimario C., Dejaegere P.P.T., Serruys P.W., Roelandt J.R.T.C. Ischemia-related lesion characteristics in patients with stable or unstable angina. A study with intracoronary angioscopy and ultrasound. Circulation. 92:1995;1408-1413.
7. Ross R. The pathogenesis of atherosclerosis a perspective for the 1990s . Nature. 362:1993;801-809.
8. Fuster V., Lewis A. Connor Memorial Lecture mechanisms leading to myocardial infarction: insights from studies of vascular biology . Circulation. 90:1994;2126-2146.
9. Falk E., Shah P.K., Fuster V. Coronary plaque disruption. Circulation. 92:1995;657-671.
10. Geng Y.-J., Libby P. Evidence for apoptosis in advanced human atheroma. Colocalization with interleukin-1-converting enzyme. Am J Pathol. 147:1995;251-266.
11. Davies M.J., Bland J.M., Hangartner J.R.W., Angelini A., Thomas A.C. Factors influencing the presence or absence of acute coronary artery thrombi in sudden ischaemic death. Eur Heart J. 10:1989;203-208.
12. Loree H.M., Kamm R.D., Stringfellow R.G., Lee R.T. Effects of fibrous cap thickness on peak circumferential stress in model atherosclerotic vessels. Circ Res. 71:1992;850-858.
13. Mann J.M., Davies M.J. Vulnerable plaque. Relation of characteristics to degree of stenosis in human coronary arteries. Circulation. 94:1996;928-931.
14. Burke A.P., Farb A., Malcolm G.T., Lang Y.H., Smialek J., Virmani R. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med. 336:1997;1276-1282.
15. Richardson P.D., Davies M.J., Born G.V.R. Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques. Lancet. 2:1989;941-944.
16. Moreno P.R., Falk E., Palacios I.F., Newell J.B., Fuster V., Fallon J.T. Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture. Circulation. 90:1994;775-778.
17. Libby P. Molecular bases of the acute coronary syndromes. Circulation. 91:1995;2844-2850.
18. Muller J.E., Abela G.S., Nesto R.W., Tofler G.H. Triggers, acute risk factors and vulnerable plaques the lexicon of a new frontier . J Am Coll Cardiol. 23:1994;809-813.
19. Farb A., Burke A.P., Tang A.L., Liang Y., Mannan P., Smialek J., Virmani R. Coronary plaque erosion without rupture into a lipid core a frequent cause of coronary thrombosis in sudden coronary death . Circulation. 93:1996;1354-1363.
20. Fernandez-Ortiz A., Badimon J.J., Falk E., Fuster V., Meyer B., Mailhac A., Weng D., Shah P.K., Badimon L. Characterization of the relative thrombogenicity of atherosclerotic plaque components implications for consequences of plaque rupture . J Am Coll Cardiol. 23:1994;1562-1569.
21. Toschi V., Gallo R., Lettino M., Fallon J.F., Gertz S.D., Fernandez-Ortiz A., Chesebro J.H., Badimon L., Nemerson Y., Fuster V., Badimon J.J. Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. Circulation. 95:1997;594-599.
22. Moreno P.R., Bernardi V.H., López-Cuéllar J., Murcia A.M., Palacios I.F., Gold H.K., Mehran R., Sharma S.K., Nemerson Y., Fuster V., Fallon J.T. Macrophages, smooth muscle cells, and tissue factor in unstable angina. Implications for cell-mediated thrombogenicity in acute coronary syndromes. Circulation. 94:1996;3090-3097.
23. Gupta S., Leatham E.W., Carrington D., Mendall M.A., Kaski J.C., Camm A.J. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation. 96:1997;404-407.
24. Randomized trial of roxithromycin in non-Q-wave coronary syndromes ROXIS pilot study . Lancet. 350:1997;404-407.
25. Kristensen S.D. The platelet-vessel wall in experimental atherosclerosis and ischaemic heart disease with special reference to thrombopoiesis. Dan Med Bull. 39:1992;110-127.
26. Merlini P.A., Bauer K.A., Oltrona L., Ardissino D., Cattaneo M., Belli C., Mannucci P.M., Rosenberg R.D. Persistent activation of coagulation mechanism in unstable angina and myocardial infarction. Circulation. 90:1994;61-68.
27. Fitzgerald D.J., Roy L., Catella F., FitzGerald G.A. Platelet activation in unstable coronary disease. N Engl J Med. 315:1986;983-989.
28. Trip M.D., Cats V.M., van Capelle F.J.L., Vreeken J. Platelet hyperreactivity and prognosis in survivors of myocardial infarction. N Engl J Med. 322:1990;1549-1554.
29. 2) polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke and venous thrombosis. Lancet. 349:1997;385-388.
30. Walter D.H., Schächinger V., Elsner M., Dimmeler S., Zeiher A.M. Platelet glycoprotein IIIa polymorphisms and risk of coronary stent thrombosis. Lancet. 350:1997;1217-1219.
31. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med. 332:1995;635-641.
32. Maseri A., Biasucci L.M., Liuzzo G. Inflammation in ishaemic heart disease-C-reactive protein concentrations may provide useful information on risk. Br J Med. 312:1996;1049-1050.